SEARCH

SEARCH BY CITATION

References

  • 1
    Williams R. Hepatology: a personal story. Clin Med 2008; 8: 2531.
  • 2
    Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates “too well for transplant, too sick for life”. JAMA 2006; 295: 21682176.
  • 3
    Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006; 35: 201219.
  • 4
    Rhee C, Broadbent AM. Palliation and liver failure: palliative medications dosage guidelines. J Palliat Med 2007; 10: 677685.
  • 5
    Tegeder I, Lotsch J, Geisslinger G. Parmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999; 37: 1740.
  • 6
    Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ 2002; 325: 929.
  • 7
    Kendall M, Harris F, Boyd K, Sheikh A, Murray SA, Brown D, et al. Key challenges and ways forward in researching the “good death”: qualitative in-depth interview and focus group study. BMJ 2007; 334: 521.
  • 8
    Prognostic Indicator Guidance to Aid Identification of Adult Patients with Advanced Disease, in the Last Months/Year of Life, Who Are in Need of Supportive and Palliative Care. Royal College of General Practitioners; Gold Standards Framework, PIP 2.24. Published June 2006. Available at: http://www.goldstandardsframework.nhs.uk.
  • 9
    Tallis R. Hippocratic Oaths: Medicine and Its Discontents. London, UK: Atlantic Books; 2004.